Page 28 - Research Models News Today

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).Animal models are predominantly used to gather information regarding the disease and its prevention,...

Congress Wealth Management LLC DE lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 4.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 50,972 shares of the medical research company’s stock after selling 2,121 shares during the quarter. Congress […]

Monarch Partners Asset Management LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 1,820 shares of the medical research company’s stock, valued at approximately $397,000. […]

Iridian Asset Management LLC CT lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 10.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 78,676 shares of the medical research company’s stock after selling 9,288 […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been given a consensus rating of “Moderate Buy” by the fourteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […]

Diametric Capital LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) during the fourth quarter, HoldingsChannel reports. The firm acquired 9,049 shares of the medical research company’s stock, valued at approximately $1,972,000. Charles River Laboratories International accounts for approximately 0.9% of Diametric Capital LP’s portfolio, making the […]

StockNews.com downgraded shares of Charles River Laboratories International (NYSE:CRL – Get Rating) from a buy rating to a hold rating in a report released on Thursday. Several other research analysts have also weighed in on the company. Guggenheim raised Charles River Laboratories International from a neutral rating to a buy rating and set a $255.00 […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the fourteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average […]

Charles River Laboratories International (NYSE:CRL – Get Rating) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday. Several other research firms have also issued reports on CRL. Jefferies Financial Group reduced their price objective on shares of Charles […]

Fifth Third Bancorp boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 14.1% in the 4th quarter, HoldingsChannel reports. The firm owned 8,094 shares of the medical research company’s stock after purchasing an additional 1,003 shares during the quarter. Fifth Third Bancorp’s holdings in Charles River Laboratories International were worth […]